ATE388962T1 - Einschlusskörper für die mündliche impfung von tieren - Google Patents

Einschlusskörper für die mündliche impfung von tieren

Info

Publication number
ATE388962T1
ATE388962T1 AT03789657T AT03789657T ATE388962T1 AT E388962 T1 ATE388962 T1 AT E388962T1 AT 03789657 T AT03789657 T AT 03789657T AT 03789657 T AT03789657 T AT 03789657T AT E388962 T1 ATE388962 T1 AT E388962T1
Authority
AT
Austria
Prior art keywords
animals
inclusion body
oral vaccination
oral
vaccination
Prior art date
Application number
AT03789657T
Other languages
English (en)
Inventor
Andrzej Plucienniczak
Malgorzata Kesik
Anna Porebska
Halina Wedrychowicz
Luiza Jedlina-Panasiuk
Original Assignee
Inst Biotechnologii I Antybiot
Inst Parazytologii Pan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Biotechnologii I Antybiot, Inst Parazytologii Pan filed Critical Inst Biotechnologii I Antybiot
Application granted granted Critical
Publication of ATE388962T1 publication Critical patent/ATE388962T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03789657T 2002-12-31 2003-12-31 Einschlusskörper für die mündliche impfung von tieren ATE388962T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL358081A PL196114B1 (pl) 2002-12-31 2002-12-31 Ciałka inkluzyjne jako antygeny do doustnej immunizacji zwierząt

Publications (1)

Publication Number Publication Date
ATE388962T1 true ATE388962T1 (de) 2008-03-15

Family

ID=32678127

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03789657T ATE388962T1 (de) 2002-12-31 2003-12-31 Einschlusskörper für die mündliche impfung von tieren

Country Status (7)

Country Link
EP (1) EP1578791B1 (de)
AT (1) ATE388962T1 (de)
AU (1) AU2003294191B2 (de)
DE (1) DE60319741T2 (de)
NZ (1) NZ541291A (de)
PL (1) PL196114B1 (de)
WO (1) WO2004058816A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ591025A (en) 2008-08-21 2013-01-25 Alvine Pharmaceuticals Inc Formulation for oral administration of proteins
EP2251025A1 (de) * 2009-05-12 2010-11-17 Universitat Autònoma De Barcelona Verwendung von Einschlusskörpern als therapeutische Wirkstoffe
NL2023863B1 (en) * 2019-09-20 2021-05-25 Univ Griffith Protein particles and uses thereof
CN116514993B (zh) * 2023-03-29 2023-09-29 中山大学附属第三医院 一种肝吸虫口服芽孢疫苗及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994017820A1 (en) * 1993-02-05 1994-08-18 Daratech Pty. Ltd. Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same
PL201419B1 (pl) * 2002-12-04 2009-04-30 Inst Biotechnologii I Antybiot Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina

Also Published As

Publication number Publication date
AU2003294191B2 (en) 2010-11-25
AU2003294191A8 (en) 2004-07-22
PL358081A1 (en) 2004-07-12
DE60319741D1 (de) 2008-04-24
NZ541291A (en) 2008-06-30
WO2004058816A3 (en) 2004-10-14
EP1578791B1 (de) 2008-03-12
DE60319741T2 (de) 2009-04-02
AU2003294191A1 (en) 2004-07-22
PL196114B1 (pl) 2007-12-31
EP1578791A2 (de) 2005-09-28
WO2004058816A2 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
BRPI0417823A (pt) métodos para uso de bifidobactérias probióticas para animais de estimação
BRPI0417825A (pt) métodos para uso de lactobacilli probióticos para animais de estimação
EA201301072A1 (ru) Антитела против il-23p19 и их применение
ITSV20030023A1 (it) Metodo per l'ottimizzazione di impulsi ad ultrasuoni in
BRPI0410861A (pt) métodos e composições para a produção de aminoácidos
EP1495118A4 (de) Starke expression immunogener proteine in den plastiden höherer pflanzen
EP1496066A4 (de) Antikörper, der proliferative humane leberzellen erkennt, proliferative humane leberzellen und funktionelle humane leberzellen
ATE511855T1 (de) Adjuvansformulierung zur scheimhaut-applikation
EP1896069A4 (de) Inaktivierte chimäre impfstoffe und entsprechende verwendungsverfahren
BRPI0406628A (pt) Determinados compostos de fosfato de aminoalquil glucosaminida e seu uso
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
BR0208896A (pt) Vacina contra o vìrus da febre do nilo
CA104143S (en) Brush
DE60319741D1 (de) Einschlusskörper für die mündliche impfung von tieren
AU158174S (en) Toothbrush
NO20044901L (no) Anvendelse av modifiserte novirhabdoviruser i vaksiner
ITRM20030555A1 (it) Prodotto di igiene buccodentale per uso umano e veterinario a base di melatonina come principio attivo.
TW200735781A (en) Food product
EA200700017A1 (ru) Способ усиления иммунного ответа на вакцину
EP3192497A8 (de) Mundpflegezusammensetzung enthaltend ein enzym und einen natürlichen gummi
AU2003294192A8 (en) Inclusion bodies as antigens for the oral vaccination of animals
IS7441A (is) Peptíðdeformýlasatálmar
AR027540A1 (es) Utilizacion de la proteina mic3 de toxoplasma gondii o de uno de sus derivados como agente inmunogeno o como antigeno de vacunacion
ITMO20040050A1 (it) Metodo per la creazione e l'elaborazione di immagini per uso odontoiatrico
DE60232650D1 (de) Peptiddeformylaseinhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties